Day One Biopharmaceuticals, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 131.16M
Gross Profit 131.16M
Operating items
Research & Development 85.62M130.52M227.70M
Selling, General & Administrative 61.29M75.54M115.45M
Other Operating Expenses 5.28M
Operating Expenses 146.91M206.06M348.43M
Operating Income -146.91M-206.06M-217.27M
EBIT -146.91M-206.06M-217.27M
Non-operating items
Non Operating Investment Income 108.00M
Interest & Investment Income 4.75M17.19M19.70M
Other Non Operating Income -0.02M-0.04M1.22M
Non Operating Income 4.73M17.15M128.92M
Net income details
EBT -142.16M-188.88M-197.57M
Tax Provisions 7.14M
Profit After Tax -142.18M-188.92M-95.50M
Income from Non-Controlling Interests 142.18M188.92M88.35M
Income from Continuing Operations -142.16M-188.88M-204.71M
Consolidated Net Income -142.16M-188.88M-204.71M
Income towards Parent Company -142.16M-188.88M-204.71M
Net Income towards Common Stockholders -142.18M-188.92M-204.71M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 60.34M61.93M73.55M87.04M100.85M
Shares Outstanding (Diluted Average) 65.47M79.77M93.23M
EBITDA -146.91M-206.06M-217.27M